Cardiovascular Effects and Risk of Syncope Related to Donepezil in Patients with Alzheimer's Disease

Author： Bordier Philippe   Garrigue Stephane   Lanusse Stephane   Margaine Julien   Robert Frederic   Gencel Laurent   Lafitte Alexia  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.5, 2006-01, pp. : 411-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Causes of Syncope in Patients with Alzheimer’s Disease Treated with Donepezil

By Bordier Philippe   Lanusse Stephane   Garrigue Stephane   Reynard Charlotte   Robert Frederic   Gencel Laurent   Lafitte Alexia  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 687-694

Adis International

Access to resources Recommend Favorite

Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients

By Perunicic-Pekovic G.   Pljesa S.   Rasic-Milutinovic Z.   Stankovic S.   Ilic M.   Maletic R.  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 4, 2008-04 ,pp. : 205-209

NRC Research Press

Access to resources Recommend Favorite

Value of donepezil doubtful in Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1444, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Risk of Bleeding Related to Antithrombotic Treatment in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5362-5378

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and Tolerability of Donepezil at Doses up to 20 mg/day: Results from a Pilot Study in Patients with Alzheimer's Disease

By Doody Rachelle S.  

Drugs & Aging, Vol. 25, Iss. 2, 2008-01 ,pp. : 163-174

Adis International

Access to resources Recommend Favorite